ASX Share rice
Wed 05 Aug 2020 - 12:46:pm (Sydney)

LGP Share Price

LITTLE GREEN PHARMA LTDLGPPharmaceuticals, Biotechnology & Life Sciences

LGP Company Information


Little Green Pharma Ltd




Drug Manufacturers—Specialty & Generic


PO Box 690 West Perth WA Australia 6872


61 8 6280 0050

MD & Director:

Ms. Fleta Jennifer Solomon

Exec. Director:

Mr. Angus McDougall Caithness

Chief Financial Officer:

Mr. Bhavesh Morar

Chief Operating Officer:

Mr. Paul Long

Gen. Counsel & Company Sec.:

Mr. Alistair Warren B.A., L.L.B.

Company Overview:

Little Green Pharma Ltd engages in the research and development, cultivation, production, manufacturing, and distribution of medicinal cannabis products in Australia and internationally. It offers a range of medical cannabis preparations in oil formulation under the LGP Natural and LGP Advanced names. The company was founded in 2016 and is headquartered in West Perth, Australia.

LGP Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


LGP CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Change To Account Receivables:


Capital Expenditures:


LGP Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Interest Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


LGP Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Long-Term Debt:


Net Receivables:




Accounts Payable:


LGP Share Price History

LGP News

20 Jul, 2020
Highlights: LGP granted ODC Medical Cannabis Cultivation and Production Permit for its expanded cultivation and manufacturing facility in Australia.Expanded Cultivation and.
28 May, 2020
April 2020 - a record sales month with 1,850+ units sold, a 17% increase on March 2020 (previous record sales month)380 new patients prescribed LGP products in April (for a.
11 May, 2020
LGP granted Manufacture Permit by the Office of Drug ControlLGP plans to commence in-house extraction operations, reducing manufacturing costs and improving manufacturing.
15 Apr, 2020
MONTRÉAL, April 15, 2020 (GLOBE NEWSWIRE) -- Elixxer Ltd. (ELXR.V)  (ELIXF) (FRA 2LQA) (“ELIXXER” or (the “Company”) is pleased to update that its pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has successfully exported their first shipment of medicinal cannabis products for patients into the UK. The products are to be distributed in the UK by Astral Health, a UK-based specialist importer and distributor of medicinal cannabis products and subsidiary of the LYPHE Group.